Sector ratings BioMarin Pharmaceutical Inc.

Equities

Market Closed - Nasdaq Other stock markets 02:30:00 19/02/2026 am IST			5-day change	1st Jan Change
61.83 ^USD	+3.14%		+2.52%	+4.04%

18/02	Tarsus Pharmaceuticals, Inc. Appoints David E. I. Pyott to Its Board of Directors and Chairperson of Commercial Committee and as Member of Nominating Committee and Compensation Committee of the Board, Effective on February 18, 2026	CI
13/02	BioMarin Pharmaceutical Inc. Announces Closing of Private Offering of Senior Notes	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation	Visibility
BIOMARIN PHARMACEUTICAL INC.	1.15TCr		BBB		-
REGENERON PHARMACEUTICALS, INC.	8.14TCr		A
UCB	6.37TCr		AA
SAMSUNG BIOLOGICS CO.,LTD.	5.48TCr		BBB
CSL LIMITED	5.16TCr		AA
BIOGEN INC.	2.87TCr		AA
INCYTE CORPORATION	2.01TCr		AA
INNOVENT BIOLOGICS, INC.	1.98TCr		AAA
MODERNA, INC.	1.72TCr	-	A	-	-
SWEDISH ORPHAN BIOVITRUM AB	1.58TCr		AA
BRIDGEBIO PHARMA, INC.	1.46TCr	-	BB	-	-
ALTEOGEN INC.	1.41TCr		CCC
AVIDITY BIOSCIENCES, INC.	1.1TCr	-	BB	-	-
AXSOME THERAPEUTICS, INC.	924.06Cr	-	BB	-	-
KRYSTAL BIOTECH, INC.	834.66Cr		B		-
GRIFOLS, S.A.	808.54Cr		BB
3SBIO INC.	754.86Cr		AA
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	735.16Cr	-	B	-	-	-
SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.	596.67Cr		BBB		-	-
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	585.7Cr		AA
Average	2.28TCr		A
Weighted average by Cap.			A